08 September 2003
Graded reoxygenation limits lipid peroxidation during surgical reperfusion
Ulf Abdel-Rahman, Tayfun Aybek, Anton Moritz, Peter Kleine, Georg MatheisMed Sci Monit 2003; 9(9): CR389-391 :: ID: 13189
Abstract
Background:Most cardiac operations with cardiopulmonary bypass (CPB) are conducted with high oxygen partial pressure. The hyperoxic reoxygenation of the ischemic heart induced by aortic declamping may be an important component of cardiac reperfusion injury. The present clinical study assessed the preventive effect of graded reoxygenation on lipid peroxidation. Malondialdehyde (MDA) levels reflect lipid peroxidation, and therefore can be used to quantify reoxygenation damage.Material/Methods:19 patients with coronary artery disease were enrolled consecutively and divided into two groups. In Group I, graded reoxygenation was initiated 1 min before, and continued for 9 min after aortic declamping (paO2: 50–70 mmHg, n=10). Patients undergoing conventional hyperoxic reoxygenation (paO2: >250 mmHg) on CPB (Group II, n=9) served as controls. Blood was collected before commencement of CPB, 2 min before release of the aortic crossclamp, 1 min and 10 min after release of the aortic crossclamp, and 3 hours after CPB.Results:MDA levels [KM/l] did not differ between groups before CPB, but 1 min after aortic declamping MDA increased significantly more in group II (11.02I1.05; p=0.04) as compared to group I (8.16I0.74). There was no difference between groups late after reperfusion.Conclusions:Hyperoxic reoxygenation by release of the aortic crossclamp is associated with increased MDA levels immediately after aortic declamping. Graded normoxic reoxygenation therefore limits lipid peroxidation in the early reperfusion period.
Keywords: Aorta - physiology, Aorta - surgery, Cardiopulmonary Bypass - adverse effects, Cardiopulmonary Bypass - methods, Lipid Peroxidation - physiology, Malondialdehyde - blood, Myocardial Reperfusion Injury - blood, Myocardial Reperfusion Injury - prevention & control, Oxygen - administration & dosage, Reperfusion - methods
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952